Table 2. Univariate and multivariate cox regression analyses for overall survival in patients with ESCC in primary cohort.
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95%CI) | P value | HR (95%CI) | P value | |
| Sex | ||||
| Male vs. Female | 0.69 (0.43–1.13) | 0.141 | ||
| Age | ||||
| ≥ 60 years vs. < 60 years | 0.94 (0.64–1.37) | 0.737 | ||
| Histological grade | 0.002* | 0.011* | ||
| Well differentiated | Ref. | Ref. | ||
| Moderately differentiated | 2.90 (0.90–9.31) | 0.074 | 1.77 (0.54–5.78) | 0.346 |
| Poorly or not differentiated | 4.87 (1.52–15.59) | 0.008* | 2.99 (0.92–9.75) | 0.069 |
| Tumor location | 0.900 | |||
| Upper | Ref. | |||
| Middle | 0.89 (0.41–1.96) | 0.778 | ||
| Lower | 0.84 (0.38–1.88) | 0.672 | ||
| Examined lymph nodes | ||||
| ≥ 15 vs. < 15 | 0.81 (0.55–1.19) | 0.285 | ||
| T stage | < 0.001* | < 0.001* | ||
| T1 | Ref. | Ref. | ||
| T2 | 2.12 (1.17–3.85) | 0.013* | 2.01 (1.10–3.68) | 0.023* |
| T3 | 3.77 (2.20–6.47) | < 0.001* | 3.46 (2.00–5.98) | < 0.001* |
| ZFAS1 | ||||
| Low vs. High | 1.89 (1.28–2.79) | 0.002* | 1.59 (1.07–2.36) | 0.022* |